معرفی
Mark Mimee is an Assistant Professor at the University of Chicago, affiliated with the Pritzker School of Molecular Engineering and the Department of Microbiology. His research leverages synthetic biology to engineer the microbiome, focusing on commensal bacteria and bacteriophage for diagnostic and therapeutic applications.
- BSc in Microbiology & Immunology, McGill University (2011)
- PhD in Microbiology, MIT (2018)
- Postdoctoral Training in Synthetic Biology, MIT (2019)
His work explores genetic manipulation of commensal microbes to create living diagnostics and cell-based therapeutics for infectious diseases and inflammatory conditions. This includes phage therapy for antibiotic-resistant infections, engineered yeast for gut inflammation mitigation, and ingestible bacterial-electronic systems for gastrointestinal monitoring.
Recent publications highlight phage cocktails targeting Klebsiella pneumoniae, CRISPR-assisted containment of engineered bacteria, and synbiotic approaches for food allergy treatment. His research spans Microbiology, Synthetic Biology, Biotechnology, and Molecular Biology.
Scientific awards include HHMI International Student Fellow and Qualcomm Innovation Fellow. He mentors a team of PhD candidates and postdoctoral associates working on Bifidobacterium immune modulation, Bacteroides prophage engineering, and microbiome biosensors.
